Apogee Therapeutics, Inc. (APGE) Capital expenditures 2023–2025
Apogee Therapeutics, Inc. (APGE) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$5.1MFY2025 · since FY2023: $167,000 → $5.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $5.1M | +346.8% |
| FY2024 | $1.2M | +589.8% |
| FY2023 | $167,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice